Large scale next-generation sequencing has evidenced that several RTKs, such as EGFR, ERBB2, IGF1R, MET and FGFR, are frequently amplified or overexpressed in HNSCC [10]. The gene discussed is MET; the disease is head and neck squamous cell carcinoma.